BioNotebook: Two new VC funds and a financing: Venrock, Accelerator, Cold Genesys
This article was originally published in Scrip
Executive Summary
Venrock has completed fundraising for a new $450m pool of money that will be invested in high-tech and health care companies on the heels of Sofinnova's new $500m venture capital fund for biotech investments (scripintelligence.com, 26 July 2014).